PledPharma AB | Innovative, unique and integrated competence in pharmaceutical drug development with focus on improving treatments for severe diseases with substantial unmet medical need where alternative treatments does not exist

PledPharma has an innovative, unique and integrated competence in pharmaceutical drug development with focus on improving treatments for severe diseases with substantial unmet medical need where alternative treatments does not exist.

More about PledPharma

Pipeline

Annual General Meeting May 7

Press Releases

May 31, 2019

PledPharma presents PledOx®’s global phase III program at ASCO

Regulatory

May 21, 2019

PledPharma completes a Directed New Share Issue of 4,866,665 shares, raising proceeds of SEK 91 million

Regulatory

May 21, 2019

PledPharma announces intention of a Directed New Share Issue

Latest Report

May 6, 2019

Latest interim report

March 29, 2018

Annual report 2017

Latest presentation

May 24, 2019

Company presentation May 2019

Calendar and upcoming reports

August 21, 2019

Half-year report, Jan-Jun

September 5, 2019

Pareto Healthcare Conference

October 23, 2019

Interim report, Jan-Sep

February 18, 2020

Year end report

Contact us

Address: Grev Turegatan 11 C, 114 46 Stockholm, Sweden

Phone: +46 8 679 72 10

E-mail: info@pledpharma.com